共 142 条
[1]
Moss SE(1991)Cause-specific mortality in a population-based study of diabetes Am J Public Health 81 1158-1162
[2]
Klein R(2006)Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies BMJ 332 73-78
[3]
Klein BE(2004)For the Conference Participants. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition Circulation 109 433-438
[4]
Huxley R(2004)Comparative effects of lipid-lowering therapies Prog Cardiovasc Dis 47 73-104
[5]
Barzi F(2008)Global coronary heart disease risk assessment of U.S. persons with the metabolic syndrome Diabetes Care 31 1405-1409
[6]
Woodward M(2000)Diabetic dyslipidaemia: current treatment recommendations Drugs 59 1101-1111
[7]
Grundy SM(2003)Advances in the understanding and management of dyslipidemia: using niacin-based therapies Am J Health Syst Pharm 60 S15-S21
[8]
Brewer HB(2005)Addressing the global cardiovascular risk of hypertension, dyslipidemia, diabetes mellitus, and the metabolic syndrome in the southeastern United States, part II: treatment recommendations for management of the global cardiovascular risk of hypertension, dyslipidemia, diabetes mellitus, and the metabolic syndrome Am J Med Sci 329 292-305
[9]
Cleeman JI(1995)Distribution of lipids in 8,500 men with coronary artery disease Am J Cardiol 75 1196-1201
[10]
Smith SC(1991)Prevalence of risk factors in men with premature coronary artery disease Am J Cardiol 67 1185-1189